Annals of Saudi medicine最新文献

{"title":"Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre.","authors":"Abdulrahman Aldakheel, Mohammed Aldehaim, Mohammed Saleh Alwhaid, Renda Alhabib, Muhammad Suhail Anwar, Balqees Alzayed, Khurram Shehzad, Hazem Ghebeh, Nasser Al-Rajhi","doi":"10.5144/0256-4947.2024.153","DOIUrl":"10.5144/0256-4947.2024.153","url":null,"abstract":"<p><strong>Background: </strong>Nasopharyngeal carcinoma (NPC) is a rare disease worldwide; To the best of our knowledge, there is no established standard of care specifically tailored for the adolescent population. The majority of existing research relies on retrospective data analysis.</p><p><strong>Objective: </strong>Evaluate clinical features, treatment results, prognostic factors and late toxicities of locally advanced NPC patients treated with tomotherapy.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Settings: </strong>Tertiary care hospital.</p><p><strong>Patients and methods: </strong>Between January 2007 and January 2020, we treated patients with NPC, aged between 14 and 21 years, with concomitant chemoradiotherapy using tomotherapy at our institution. We prospectively collected details of clinical characteristics, treatment modalities, outcomes and prognostic factors of these patients and then analysed them retrospectively.</p><p><strong>Main outcome measures: </strong>3-5 years overall survival (OS), 3-5 years locoregional control rate, 3-5 years disease-free survival (DFS), prognostic factors.</p><p><strong>Sample size: </strong>51 patients.</p><p><strong>Results: </strong>There were 26 male and 25 female patients included in our study. The mean age was 16.5 years, 5 (9.8%) patients with stage III, and 46 (90.2%) with stage IVa according to the American Joint Committee on Cancer, 8th edition staging system. Most patients (98%) received two or more cycles of induction chemotherapy. All patients received concomitant chemoradiotherapy. The median total dose of radiotherapy delivered was 6600 cGy (range 4800-7000). With a median follow-up of 73 months (range 9-168 months), a 5-year locoregional control rate, 5-year OS and 5-year DFS rates were 100%, 86.8% and 71.7%, respectively. Five years later, disease control was 71.7%. Ten (19.6%) patients had disease recurrence in the form of distant metastases during the follow up.</p><p><strong>Conclusions: </strong>Helical tomotherapy has an excellent late toxicity profile without compromising clinical outcome for patients with NPC. Radiotherapy remains the mainstay of treatment of nasopharyngeal carcinoma to achieve remarkable local control rates.</p><p><strong>Limitations: </strong>Single institution experience, small number of patients, and retrospective design.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of TLR4 gene rs4986790 and rs4986791 polymorphisms with asthma susceptibility: meta-analysis and trial sequential analysis.","authors":"Nan Guo, Haokun Tian, Tiangang Song, Yu Peng","doi":"10.5144/0256-4947.2024.183","DOIUrl":"10.5144/0256-4947.2024.183","url":null,"abstract":"<p><strong>Background: </strong>The current understanding of the correlation between TLR4 gene (toll-like receptor 4) rs4986790 and rs4986791 polymorphisms and asthma susceptibility is inconclusive, with studies and populations yielding conflicting results.</p><p><strong>Objectives: </strong>Evaluate this relationship using meta-analysis and trial sequential analysis (TSA).</p><p><strong>Patients and methods: </strong>Databases were systematically queried for relevant articles from the establishment of the database to 19 June 2023 adhering to predefined inclusion and exclusion criteria. Two authors independently conducted screening, data extraction, and quality evaluation. Meta-analysis and TSA were carried out using RevMan 5.4, StataMP 17.0, and TSA 0.9.5.10 Beta, with α=0.05. Subgroup analyses were conducted based on racial demographics. A sensitivity analysis was conducted employing a one-by-one exclusion method. Publication bias was assessed using the Begg and Egger tests.</p><p><strong>Main outcome measures: </strong>Association of asthma susceptibility with TLR4 gene rs4986790 and rs4986791 polymorphisms.</p><p><strong>Sample size: </strong>23 articles included 22 studies on the rs4986790 polymorphism and 11 studies on the rs4986791 polymorphism on the TLR4 gene.</p><p><strong>Results: </strong>Out of 692 studies screened, 23 met the inclusion criteria. While the overall meta-analysis showed no significant association between the TLR4 rs4986790 polymorphism and asthma susceptibility, subgroup analysis revealed a significant link in the Caucasian population. A significant association was noted in the meta-analysis, particularly among Asian populations, on the rs4986791 polymorphism. The sensitivity analysis indicated that the meta-analysis results were relatively stable. Publication bias analysis revealed minimal influence from publication bias. However, TSA was underscored by the necessity for additional original studies to further validate specific outcomes.</p><p><strong>Conclusions: </strong>Our study underscores the ethnicity-specific impact on the relationship between TLR4 polymorphisms and asthma susceptibility. While the overall findings for rs4986790 were not significant, the association with the Caucasian population merits further investigation. Furthermore, rs4986791 demonstrated a significant correlation with asthma susceptibility, specifically among Asian populations.</p><p><strong>Limitations: </strong>Our study predominantly examined the rs4986790 and rs4986791 polymorphisms, overlooking the potential influence of other genetic variants within TLR4.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mesenchymal stem cells and platelet rich plasma therapy for knee osteoarthritis: an umbrella review of systematic reviews with meta-analysis.","authors":"Feng Lin, Xinguang Zhang, Cunbao Cui","doi":"10.5144/0256-4947.2024.195","DOIUrl":"10.5144/0256-4947.2024.195","url":null,"abstract":"<p><p>The effect of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) therapy on knee osteoarthritis (KOA) has been contradictory in previous meta-analyses. This umbrella review on published meta-analyses aimed to investigate the effect of MSCs and PRP on KOA. We systematically searched Scopus, PubMed, and Cochrane databases to include related meta-analyses. The outcome included studies reporting visual analog scale scores, the Western Ontario and McMaster Universities Osteoarthritis Index, Whole-Organ Magnetic Resonance Imaging Scores, International Knee Documentation Committee scores, and the Knee injury and Osteoarthritis Outcome Score. A total of 28 meta-analyses with 32 763 participants. MSCs and PRP therapies were significantly associated with an improvement in KOA scores. This umbrella meta-analysis supports the beneficial health effects of MSCs and PRP in KOA.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The prevalence of acute kidney injury in patients with community-acquired pneumonia who required mechanical ventilation.","authors":"Abdulmajed Almutairi, Farhan Alenezi, Hani Tamim, Musharaf Sadat, Felwa Bin Humaid, Amal AlMatrood, Yadullah Syed, Yaseen Arabi","doi":"10.5144/0256-4947.2024.104","DOIUrl":"https://doi.org/10.5144/0256-4947.2024.104","url":null,"abstract":"<p><strong>Background: </strong>Community-acquired pneumonia (CAP) is a common reason for intensive care unit (ICU) admission and sepsis. Acute kidney injury (AKI) is a frequent complication of community-acquired pneumonia and is associated with increased short- and long-term morbidity and mortality and healthcare costs.</p><p><strong>Objective: </strong>Describe the prevalence of AKI in patients with CAP requiring mechanical ventilation and evaluate its association with inhospital mortality.</p><p><strong>Design: </strong>Retrospective cohort.</p><p><strong>Setting: </strong>Intensive care unit.</p><p><strong>Patients and methods: </strong>We included patients with CAP on mechanical ventilation. Patients were categorized according to the development of AKI in the first 24 hours of ICU admission using the Kidney Disease Improving Global Outcomes (KDIGO) classification from no AKI, stage 1 AKI, stage 2 AKI, and stage 3 AKI.</p><p><strong>Main outcome measures: </strong>The primary outcome was hospital mortality. Secondary outcomes were ICU mortality, hospital and ICU length of stay, ventilation duration, tracheostomy, and renal replacement therapy requirement.</p><p><strong>Results: </strong>Of 1536 patients included in the study, 829 patients (54%) had no AKI while 707 (46%) developed AKI. In-hospital mortality was 288/829 (34.8%) for patients with no AKI, 43/111 (38.7%) for stage 1 AKI, 86/216 (40%) for stage 2 AKI, and 196/380 (51.7%) for stage 3 AKI (<i>P</i><.0001). Multivariate analysis revealed that stages 1, 2, or 3 AKI compared to no AKI were not independently associated with in-hospital mortality. Older age, vasopressor use; decreased Glasgow coma scale, PaO₂/Fio₂ ratio and platelet count, increased bilirubin, lactic acid and INR were associated with increased mortality while female sex was associated with reduced mortality.</p><p><strong>Conclusion: </strong>Among mechanically ventilated patients with CAP, AKI was common and was associated with higher crude mortality. The higher mortality could not be attributed alone to AKI, but rather appeared to be related to multi-organ dysfunction.</p><p><strong>Limitations: </strong>Single-center retrospective study with no data on baseline serum creatinine and the use of estimated baseline creatinine distributions based on the MDRD (Modification of Diet in Renal Disease)equation which may lead to an overestimation of AKI. Second, we did not have data on the microbiology of pneumonia, appropriateness of antibiotic therapy or the administration of other medications that have been demonstrated to be associated with AKI.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.","authors":"Ahmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, Hazaa Al Zahrani, Ruah Al Yamany, Mostafa Saleh, Saud Alhayli, Zakia Al Somali, Ahmad Alotaibi, AlFadel AlShaibani, Farah Deeba, Maryam Asif, Syed Ahmed Osman Ali Ahmed, Feras Al Fraih, Marwan Shaheen, Ali Alahmari, Walid Rasheed, Naeem Arshad Chaudhri, Fahad Al Mohareb, Mahmoud Aljurf, Amr Hanbali","doi":"10.5144/0256-4947.2024.93","DOIUrl":"https://doi.org/10.5144/0256-4947.2024.93","url":null,"abstract":"<p><strong>Background: </strong>Multiple myeloma (MM) represents the second most common hematologic malignancy (15%). Induction with bortezomib, cyclophosphamide, and dexamthasone VCd (d: low dose dexamthasone) regimen is widely used due to its high effectiveness, low toxicity and good tolerability, particularly with renal impairment. Real-world data on the use of VCD in clinical practice is lacking.</p><p><strong>Objectives: </strong>Evaluate the real-world experience of the VCD regimen.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Setting: </strong>Tumor registry database of tertiary cancer care center.</p><p><strong>Patients and methods: </strong>newly diagnosed MM patients who received VCD induction and underwent autologous stem cell transplant (ASCT) from July 2007 to July 2020.</p><p><strong>Main outcome measures: </strong>response evaluation, progression-free survival (PFS) and overall survival (OS).</p><p><strong>Sample size: </strong>87 patients.</p><p><strong>Results: </strong>Of 102 patients who started induction with VCd, 87 patients experienced a partial response or more overall response rate of 85%). The median age of these 87 patients at diagnosis was 52 years, of which 29.9% presented with renal impairment and 60.3% of patients had stage 2 by the Revised International Staging System (R-ISS). Patients with a standard cytogenetic risk achieved a better response compared to those with a poor cytogenetic risk (<i>P</i>=.044). The post-induction response rates were 6.9% stringent complete remission (sCR), 35% complete remission (CR); 41.4% very good partial response (VGPR), and 16.1% partial response (PR), respectively; the response rates became greater for sCR and CR post-transplantation at day 100 with 16.1% sCR, 35.6% CR, 32.2% VGPR and 16.1% PR, respectively. The median PFS was 49 months and 5 years OS was 84%. PFS was better in patients who achieved sCR vs PR (83 vs 35 months, <i>P</i>=.037). High LDH, high-risk cytogenetic and stage 3 R-ISS showed a worse median PFS and OS.</p><p><strong>Conclusions: </strong>VCD induction in newly diagnosed MM is highly effective, convenient, tolerable and affordable regimen, especially in low and middle-income countries with limited resources, also with favorable outcomes and survival. while those who did not respond successfully shifted to VRD or VTD.</p><p><strong>Limitations: </strong>The usual limitations of a retrospective analysis using registry-level data, no data on quality of life.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Microorganism diversity and contamination risk in mosque rosaries and carpets.","authors":"Metin Özdemir, Erhan Karat, Ünsal Savci, Hacer Isler","doi":"10.5144/0256-4947.2024.67","DOIUrl":"https://doi.org/10.5144/0256-4947.2024.67","url":null,"abstract":"<p><strong>Background: </strong>Inevitably, the floors of mosques are contaminated with microorganisms, and the risk of pathogen transmission is probably high between the many visitors, but the issue has been infrequently studied.</p><p><strong>Objectives: </strong>Investigate microorganism variety and risk of contamination on commonly used carpets and rosaries (prayer beads).</p><p><strong>Design: </strong>Cross-sectional.</p><p><strong>Settings: </strong>Mosques.</p><p><strong>Methods: </strong>This study was carried out in three different cities of Turkey in 2023, focusing on mosques located around hospitals. Forty mosques were included in the study and from each mosque 10 samples were collected from various parts of carpets and rosaries. The number of positive culture isolates were identified.</p><p><strong>Main outcome measures: </strong>Diversity and distribution of microorganisms isolated from mosque carpets and rosaries; methicillin-resistance rates in <i>Staphylococci</i>.</p><p><strong>Sample size: </strong>400 samples.</p><p><strong>Results: </strong>Growth was observed in 368 (92%) of 400 samples examined. The microorganisms isolated in the highest number were methicillin-susceptible coagulase negative <i>Staphylococci</i> (MSCoNS) (59.8%), <i>Microcooccus</i> (41%) and diphtheroids (31.3%). The rates of total growth (<i>P</i>=.001), including diphtheroids (<i>P</i>=.018), methicillin-resistant coagulase negative <i>Staphylococci</i> (P=.001), <i>Bacillus spp.</i> (<i>P</i>=.036) and <i>Aspergillus spp.</i> (<i>P</i>=.002) rates were significantly higher in the rosary samples than carpet samples. At mosques in Tokat, a province center, 4 samples were positive for <i>Acinetobacter baumannii</i>, two samples were positive for <i>Pseudomonas aeruginosa</i> and one sample for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), and these were isolated from rosaries. 0.3% of <i>Staphylococcus</i> isolates were MRSA.</p><p><strong>Conclusion: </strong>As there is a high risk of contamination of carpets and prayer beads on the mosque floor with human flora, the use of appropriate hygiene practices is necessary. We also found some emerging bacteria in addition to the normal human flora.</p><p><strong>Limitations: </strong>Our study was conducted in three provinces. Further studies might cover a wider geography.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016149/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predicting COVID-19 outcomes with the Edmonton Obesity Staging System.","authors":"Sajjad Ali, Omar Sufyan Khan, Amira M Youssef, Iram Saba, Leena Alqahtani, Renad Abdulaziz Alduhaim, Renad Almesned","doi":"10.5144/0256-4947.2024.116","DOIUrl":"https://doi.org/10.5144/0256-4947.2024.116","url":null,"abstract":"<p><strong>Background: </strong>Multiple studies have demonstrated a correlation between a high body mass index and discriminatory COVID-19 outcomes. Studies appear to indicate that there is a correlation between obesity-related comorbidities and less favorable outcomes.</p><p><strong>Objectives: </strong>The primary aim of the current investigation is to conduct a thorough assessment of the correlation between BMI and comorbidities associated with obesity, and their potential impact on the severity and consequences of COVID-19 infection among patients receiving care in a tertiary healthcare setting.</p><p><strong>Design: </strong>Retrospective cohort.</p><p><strong>Settings: </strong>Tertiary rehabilitation center, Riyadh, Saudi Arabia.</p><p><strong>Patients and methods: </strong>The study included all individuals who received medical treatment and tested positive for COVID-19 by means of RT-PCR during the period from March to September 2020. COVID-19 patients were classified using Edmonton Obesity Staging System (EOSS).</p><p><strong>Main outcome measures: </strong>COVID-19-related complications, including pneumonia and cytokine release syndrome, as well as the time length to COVID-19 negativization.</p><p><strong>Sample size: </strong>315 patients.</p><p><strong>Results: </strong>The median (25th-75th percentiles) age of the patients was 38 (31.5-49) years old. Males outnumbered females, and 66% of patients were non-Saudis. Forty-eight patients (15.2%) had obesity class I, whereas 13 patients (4.1%) had class II. Thirty-two patients (10.2%) were classified as EOSS stage 1, 105 patients (33.3%) were classified as EOSS stage 2, and 25 patients (7.9%) were assigned to EOSS stage 3. Males predominated in EOSS stages 1 and 2, whereas females predominated in stage 3. In EOSS stage 3, 52% of cases had moderate severity and 48% had severe illness.</p><p><strong>Conclusions: </strong>EOSS distinguishes the COVID-19 risks of poor outcomes beyond BMI. Patients who were overweight or obese but remained in the stage 1 of the EOSS had a lower risk of a poor COVID-19 outome than normal-weight patients. The health status of obese patients is a more precise indicator of the progression of COVID-19 during hospitalization than BMI alone.</p><p><strong>Limitations: </strong>Given the limited capacity of urgent care facilities to conduct a comprehensive evaluation of comorbidities and other relevant outcomes in all patients, it is plausible that certain patients may have been erroneously classified with an EOSS stage 2 diagnosis, when in fact they ought to have been assigned a stage 3 diagnosis.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical profile of functional constipation in Saudi children.","authors":"Mohammad El Mouzan, Mohammed Kambal, Hayfa Alabdulkarim, Nawaf Rahi Alshammari, Rehab Alanazi, Ahmed Al Sarkhy, Nouf Alhamid, Asaad Muhammed Assiri, Alhanouf Alzahrani, Shaffi Ahamed Shaik, Mona Alasmi","doi":"10.5144/0256-4947.2024.111","DOIUrl":"https://doi.org/10.5144/0256-4947.2024.111","url":null,"abstract":"<p><strong>Background: </strong>Functional constipation (FC) is a common condition in children, and information on the clinical characteristics of FC in Saudi children is scarce.</p><p><strong>Objective: </strong>Describe the clinical profile of FC in Saudi children.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Setting: </strong>Hospital that provides primary, intermediate and tertiary care.</p><p><strong>Patients and methods: </strong>All children diagnosed with FC according to the Rome IV criteria were included and had at least one follow-up clinic visit. Demographic and clinical data collected from medical records included the age at onset, duration of constipation, clinical features, treatment modalities, and factors associated with clinical response. Descriptive statistics and Pearson's chi-squared test were used in the statistical analysis to see how categorical study variables were linked to clinical response. A P value of ≤.05 was used to report statistical significance.</p><p><strong>Main outcome measure: </strong>Compliance and clinical response to polyethylene glycol (PEG) compared with lactulose.</p><p><strong>Sample size: </strong>370 children from 0.1 to 13 years of age.</p><p><strong>Results: </strong>The median (IQR) age of onset was 4 (5) years and less than one year in 14%. The median (IQR) duration of constipation was 4 months (11) and less than two months in 93/370 (25%). Abdominal pain was the most commonly associated feature (44%). Screening for celiac disease and hypothyroidism was negative. A Fleet enema was the most common disimpaction method (54%) and PEG was the most common maintenance medication (63.4%). PEG was significantly better tolerated (<i>P</i>=.0008) and more effective than lactulose (<i>P</i><.0001). Compliance was the only variable significantly associated with clinical response.</p><p><strong>Conclusions: </strong>PEG was better tolerated and more effective than lactulose in our study, a finding in agreement with the literature. Therefore, PEG should be the drug of choice in the initial management of FC in Saudi children. Prospective studies on the causes of noncompliance are needed to improve the response to treatment.</p><p><strong>Limitations: </strong>The limitations of retrospective design are missing data, recall bias, and hospital-based limitation, such as missing milder cases treated at the outpatient level. However, the sample size of 370 may have minimized these limitations.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metformin and risk of hematological cancers in patients with diabetes: a systematic review and meta-analysis.","authors":"Min Wang, Giti Noghabaei, Tahereh Raeisi, Dandan Li, Hamzeh Alizadeh, Mohammad Alizadeh","doi":"10.5144/0256-4947.2024.126","DOIUrl":"10.5144/0256-4947.2024.126","url":null,"abstract":"<p><strong>Funding: </strong>No external funding.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140869726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The variation in preventable hospitalization in patients with type 2 diabetes in Kentucky before and after the Medicaid expansion.","authors":"Turky Arbaein, Bert Little, Sarah Monshi, Ahmed M Al-Wathinani, Amal Zaidan","doi":"10.5144/0256-4947.2024.73","DOIUrl":"https://doi.org/10.5144/0256-4947.2024.73","url":null,"abstract":"<p><strong>Background: </strong>Hospitalizations are more resource intensive and expensive than outpatient care. Therefore, type 2 diabetes-related preventable hospitalization are a major topic of research efficiency in the healthcare system.</p><p><strong>Objectives: </strong>Analyze county level variation in type 2 diabetes-related preventable hospitalization rates in Kentucky before the Medicaid expansion (2010-2013) and after the Medicaid expansion (2014-2017).</p><p><strong>Design: </strong>Geographic mapping and cluster analysis.</p><p><strong>Setting: </strong>Data for a state of the United States of America.</p><p><strong>Methods: </strong>We used the KID data to generate geographic mapping for type 2 diabetes-related preventable hospitalizations to visualize rates. We included all Kentucky discharges of age 18 years and older with the ICD9/10 principal diagnosis code for type 2 diabetes. Then, we conducted cluster analysis techniques to compare county-level variation in type 2 diabetes-related preventable hospitalization rates across Kentucky counties pre- and post-Medicaid expansion.</p><p><strong>Main outcome and measures: </strong>County type 2 diabetes-related preventable hospitalization pre- and post-Medicaid expansion.</p><p><strong>Results: </strong>From 2010-2017, type 2 diabetes-related preventable hospitalization discharge rates reduced significantly in the period of the post-Medicaid expansion (<i>P</i>=.001). The spatial statistics analysis revealed a significant spatial clustering of counties with similar rates of type 2 diabetes-related preventable hospitalization in the south, east, and southeastern Kentucky pre- and post-Medicaid expansion (positive z-score and positive Moran's Index value (<i>P</i>>.05). Also, there was a significant clustering of counties with low type 2 diabetes-related preventable hospitalization rates in the north, west, and central regions of the state pre-Medicaid expansion and post-Medicaid expansion (positive z-score and positive Moran's Index value (<i>P</i>>.05).</p><p><strong>Conclusion: </strong>Kentucky counties in the southeast have experienced a significant clustering of highly avoidable hospitalization rates during both periods. Focusing on the vulnerable counties and the economic inequality in Kentucky could lead to efforts to lowering future type 2 diabetes-related preventable hospitalization rates.</p><p><strong>Limitations: </strong>We used de-identified data which does not provide insights into the frequency of hospitalizations per patient. An individual patient may be hospitalized several times and counted as several individuals.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}